SuperworthXBiotech shares outstanding XBIT
Diluted shares outstanding, averaged over each quarter, from 2014.
- Latest quarter, to Dec 31, 2021
- 30.4M
- On a year earlier
- +3.9%
- more shares
XBiotech had 30.4M diluted shares outstanding on average in Q4 FY21, the quarter to Dec 31, 2021.
That is 3.9% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2021 | 30.4M | +4% |
| FY2020 | 29.3M | −40% |
| FY2019 | 48.6M | +36% |
| FY2018 | 35.8M | +11% |
| FY2017 | 32.3M | −1% |
| FY2016 | 32.5M | +1% |
| FY2015 | 32.2M | +29% |
| FY2014 | 25M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q4 FY21 | 30.4M | +4% | |
| Q3 FY21 | 30.3M | +4% | |
| Q2 FY21 | 30M | +4% | |
| Q1 FY21 | 29.4M | −19% | |
| Q4 FY20 | 29.3M | −40% | |
| Q3 FY20 | 29M | −29% | |
| Q2 FY20 | 28.9M | −23% | |
| Q1 FY20 | 36.2M | +1% | |
| Q4 FY19 | 48.6M | +36% | |
| Q3 FY19 | 41M | +15% | |
| Q2 FY19 | 37.5M | +5% | |
| Q1 FY19 | 36M | +1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on XBiotech
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.